PetCaseFinder

Peer-reviewed veterinary case report

Sentinel lymph node mapping changes treatment for dogs with mast cell

By Worley, Deanna R·Published in Veterinary and comparative oncology·2014·Department of Clinical Sciences, United States·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Incorporation of sentinel lymph node mapping in dogs with mast cell tumours: 20 consecutive procedures.

Species:
dog

Plain-English summary

A group of 19 dogs with mast cell tumors (a type of skin cancer) underwent a special procedure called sentinel lymph node mapping to help determine if they needed additional treatment after surgery. During the procedure, the veterinarians used a combination of imaging and dye to identify which lymph nodes were most affected by the cancer. As a result, 8 of the dogs were recommended for extra therapy that they wouldn't have received otherwise. This approach helps ensure that dogs with mast cell tumors get the most appropriate care based on their specific situation.

People also search for: dog mast cell tumor treatment · sentinel lymph node mapping dogs · mast cell tumor surgery recovery

Abstract

The study hypothesis is that incorporation of sentinel lymph node (SLN) mapping in dogs presenting for mast cell tumour (MCT) removal would impact the recommended adjuvant therapy offered. Nineteen dogs were enrolled having either spontaneously occurring or incompletely excised MCTs. Staging included regional lymph node aspiration. SLN mapping was done with regional lymphoscintigraphy combined with intra-operative lymphoscintigraphy and blue dye. Twenty MCTs in 19 dogs were excised with SLN mapping. Eight dogs had SLNs different from the closest node. Twelve dogs had metastasis in extirpated SLNs, seven occurred in MCTs with a MI ≤ 5. No correlation was noted between patient stage and the c-KIT proto-oncogene. Because of SLN staging, 8 of 19 dogs were offered additional therapy that would have otherwise been excluded. Anatomic sampling of lymph nodes in dogs with MCTs does not accurately reflect which lymph nodes are most likely to be receiving the draining tumour lymph.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/22958227/